Literature DB >> 25596525

15q11.2 microdeletion (BP1-BP2) and developmental delay, behaviour issues, epilepsy and congenital heart disease: a series of 52 patients.

Clémence Vanlerberghe1, Florence Petit2, Valérie Malan3, Catherine Vincent-Delorme2, Sonia Bouquillon4, Odile Boute2, Muriel Holder-Espinasse5, Bruno Delobel6, Bénédicte Duban6, Louis Vallee7, Jean-Marie Cuisset7, Marie-Pierre Lemaitre7, Marie-Christine Vantyghem8, Marie Pigeyre8, Sandrine Lanco-Dosen9, Ghislaine Plessis10, Marion Gerard10, Matthieu Decamp10, Michèle Mathieu11, Gilles Morin11, Guillaume Jedraszak11, Frédéric Bilan12, Brigitte Gilbert-Dussardier13, Delphine Fauvert14, Joëlle Roume15, Valérie Cormier-Daire16, Roseline Caumes16, Jacques Puechberty17, David Genevieve17, Pierre Sarda17, Lucie Pinson17, Patricia Blanchet17, Nathalie Lemeur18, Frenny Sheth19, Sylvie Manouvrier-Hanu2, Joris Andrieux4.   

Abstract

Proximal region of chromosome 15 long arm is rich in duplicons that, define five breakpoints (BP) for 15q rearrangements. 15q11.2 microdeletion between BP1 and BP2 has been previously associated with developmental delay and atypical psychological patterns. This region contains four highly-conserved and non-imprinted genes: NIPA1, NIPA2, CYFIP1, TUBGCP5. Our goal was to investigate the phenotypes associated with this microdeletion in a cohort of 52 patients. This copy number variation (CNV) was prevalent in 0.8% patients presenting with developmental delay, psychological pattern issues and/or multiple congenital malformations. This was studied by array-CGH at six different French Genetic laboratories. We collected data from 52 unrelated patients (including 3 foetuses) after excluding patients with an associated genetic alteration (known CNV, aneuploidy or known monogenic disease). Out of 52 patients, mild or moderate developmental delay was observed in 68.3%, 85.4% had speech impairment and 63.4% had psychological issues such as Attention Deficit and Hyperactivity Disorder, Autistic Spectrum Disorder or Obsessive-Compulsive Disorder. Seizures were noted in 18.7% patients and associated congenital heart disease in 17.3%. Parents were analysed for abnormalities in the region in 65.4% families. Amongst these families, 'de novo' microdeletions were observed in 18.8% and 81.2% were inherited from one of the parents. Incomplete penetrance and variable expressivity were observed amongst the patients. Our results support the hypothesis that 15q11.2 (BP1-BP2) microdeletion is associated with developmental delay, abnormal behaviour, generalized epilepsy and congenital heart disease. The later feature has been rarely described. Incomplete penetrance and variability of expression demands further assessment and studies.
Copyright © 2015. Published by Elsevier Masson SAS.

Entities:  

Keywords:  15q11.2 microdeletion; BP1–BP2; CYFIP1; Congenital heart disease; NIPA1; NIPA2; TUBGCP5

Mesh:

Substances:

Year:  2015        PMID: 25596525     DOI: 10.1016/j.ejmg.2015.01.002

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  31 in total

Review 1.  Elucidating the mechanisms of transcription regulation during heart development by next-generation sequencing.

Authors:  Keisuke Nimura; Yasufumi Kaneda
Journal:  J Hum Genet       Date:  2015-07-23       Impact factor: 3.172

2.  Domain-Specific Cognitive Impairments in Humans and Flies With Reduced CYFIP1 Dosage.

Authors:  Young Jae Woo; Alexandros K Kanellopoulos; Parisa Hemati; Jill Kirschen; Rebecca A Nebel; Tao Wang; Claudia Bagni; Brett S Abrahams
Journal:  Biol Psychiatry       Date:  2019-04-17       Impact factor: 13.382

Review 3.  The genetics of congenital heart disease… understanding and improving long-term outcomes in congenital heart disease: a review for the general cardiologist and primary care physician.

Authors:  M Abigail Simmons; Martina Brueckner
Journal:  Curr Opin Pediatr       Date:  2017-10       Impact factor: 2.856

Review 4.  [Genetic findings in autism spectrum disorders].

Authors:  C M Freitag
Journal:  Nervenarzt       Date:  2017-07       Impact factor: 1.214

5.  Major Contribution of Genomic Copy Number Variation in Syndromic Congenital Heart Disease: The Use of MLPA as the First Genetic Test.

Authors:  Rejane A C Monteiro; Mariana L de Freitas; Gabrielle S Vianna; Valdirene T de Oliveira; Rafaella X Pietra; Luana C A Ferreira; Patrícia P O Rocha; Michele da S Gonçalves; Giovana da C César; Joziele de S Lima; Paula F V Medeiros; Juliana F Mazzeu; Fernanda S Jehee
Journal:  Mol Syndromol       Date:  2017-06-14

6.  Variable Penetrance of the 15q11.2 BP1-BP2 Microduplication in a Family with Cognitive and Language Impairment.

Authors:  Antonio Benítez-Burraco; Montserrat Barcos-Martínez; Isabel Espejo-Portero; Salud Jiménez-Romero
Journal:  Mol Syndromol       Date:  2017-04-14

7.  SNP array screening of cryptic genomic imbalances in 450 Japanese subjects with intellectual disability and multiple congenital anomalies previously negative for large rearrangements.

Authors:  Daniela Tiaki Uehara; Shin Hayashi; Nobuhiko Okamoto; Seiji Mizuno; Yasutsugu Chinen; Rika Kosaki; Tomoki Kosho; Kenji Kurosawa; Hiroshi Matsumoto; Hiroshi Mitsubuchi; Hironao Numabe; Shinji Saitoh; Yoshio Makita; Akira Hata; Issei Imoto; Johji Inazawa
Journal:  J Hum Genet       Date:  2016-01-07       Impact factor: 3.172

8.  High-dose folic acid supplementation alters the human sperm methylome and is influenced by the MTHFR C677T polymorphism.

Authors:  Mahmoud Aarabi; Maria C San Gabriel; Donovan Chan; Nathalie A Behan; Maxime Caron; Tomi Pastinen; Guillaume Bourque; Amanda J MacFarlane; Armand Zini; Jacquetta Trasler
Journal:  Hum Mol Genet       Date:  2015-08-24       Impact factor: 6.150

9.  Familial total anomalous pulmonary venous return with 15q11.2 (BP1-BP2) microdeletion.

Authors:  Yukiko Kuroda; Ikuko Ohashi; Takuya Naruto; Kazumi Ida; Yumi Enomoto; Toshiyuki Saito; Jun-Ichi Nagai; Sadamitsu Yanagi; Hideaki Ueda; Kenji Kurosawa
Journal:  J Hum Genet       Date:  2018-08-14       Impact factor: 3.172

10.  Cyfip1 Regulates Presynaptic Activity during Development.

Authors:  Kuangfu Hsiao; Hala Harony-Nicolas; Joseph D Buxbaum; Ozlem Bozdagi-Gunal; Deanna L Benson
Journal:  J Neurosci       Date:  2016-02-03       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.